| Dr Heriberto Alfredo Tejeda, MD, MPH | |
|
600 Elizabeth St, Corpus Christi, TX 78404-2235 | |
| (361) 884-2904 | |
| (361) 857-0572 |
| Full Name | Dr Heriberto Alfredo Tejeda |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 600 Elizabeth St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396785887 | NPI | - | NPPES |
| 042930003 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | K8518 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christus Spohn Hospital Corpus Christi | Corpus christi, TX | Hospital |
| Christus Spohn Hospital Alice | Alice, TX | Hospital |
| Christus Spohn Hospital Beeville | Beeville, TX | Hospital |
| Corpus Christi Medical Center,the | Corpus christi, TX | Hospital |
| Christus Spohn Hospital Kleberg | Kingsville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inpatient Consultants Of Corpus Christi Pllc | 7810382140 | 2 |
News Archive
The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Scientists at the University of Notre Dame have found that exposure to just 10 minutes of light at night suppresses biting and manipulates flight behavior in the Anopheles gambiae mosquito, the major vector for transmission of malaria in Africa, according to new research published in the journal Parasites and Vectors.
Shire plc, the global specialty biopharmaceutical company, today announced positive data from its long-term extension to its open label Phase I/II study (TKT-025 EXT) for VPRIV® (velaglucerase alfa), the company's enzyme replacement therapy for patients with type 1 Gaucher disease. The data were presented at the 9th Annual European Working Group on Gaucher Disease (EWGGD) in Cologne, Germany, and add to the growing body of clinical evidence which supports the safety and sustained efficacy of VPRIV.
› Verified 5 days ago
| Entity Name | Lonestar Hospital Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518237429 PECOS PAC ID: 6709049703 Enrollment ID: O20120530000620 |
News Archive
The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Scientists at the University of Notre Dame have found that exposure to just 10 minutes of light at night suppresses biting and manipulates flight behavior in the Anopheles gambiae mosquito, the major vector for transmission of malaria in Africa, according to new research published in the journal Parasites and Vectors.
Shire plc, the global specialty biopharmaceutical company, today announced positive data from its long-term extension to its open label Phase I/II study (TKT-025 EXT) for VPRIV® (velaglucerase alfa), the company's enzyme replacement therapy for patients with type 1 Gaucher disease. The data were presented at the 9th Annual European Working Group on Gaucher Disease (EWGGD) in Cologne, Germany, and add to the growing body of clinical evidence which supports the safety and sustained efficacy of VPRIV.
› Verified 5 days ago
| Entity Name | Inpatient Consultants Of Corpus Christi Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578210696 PECOS PAC ID: 7810382140 Enrollment ID: O20220323000055 |
News Archive
The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Scientists at the University of Notre Dame have found that exposure to just 10 minutes of light at night suppresses biting and manipulates flight behavior in the Anopheles gambiae mosquito, the major vector for transmission of malaria in Africa, according to new research published in the journal Parasites and Vectors.
Shire plc, the global specialty biopharmaceutical company, today announced positive data from its long-term extension to its open label Phase I/II study (TKT-025 EXT) for VPRIV® (velaglucerase alfa), the company's enzyme replacement therapy for patients with type 1 Gaucher disease. The data were presented at the 9th Annual European Working Group on Gaucher Disease (EWGGD) in Cologne, Germany, and add to the growing body of clinical evidence which supports the safety and sustained efficacy of VPRIV.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Heriberto Alfredo Tejeda, MD, MPH Po Box 61160, Corpus Christi, TX 78466-1160 Ph: (361) 884-2904 | Dr Heriberto Alfredo Tejeda, MD, MPH 600 Elizabeth St, Corpus Christi, TX 78404-2235 Ph: (361) 884-2904 |
News Archive
The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Scientists at the University of Notre Dame have found that exposure to just 10 minutes of light at night suppresses biting and manipulates flight behavior in the Anopheles gambiae mosquito, the major vector for transmission of malaria in Africa, according to new research published in the journal Parasites and Vectors.
Shire plc, the global specialty biopharmaceutical company, today announced positive data from its long-term extension to its open label Phase I/II study (TKT-025 EXT) for VPRIV® (velaglucerase alfa), the company's enzyme replacement therapy for patients with type 1 Gaucher disease. The data were presented at the 9th Annual European Working Group on Gaucher Disease (EWGGD) in Cologne, Germany, and add to the growing body of clinical evidence which supports the safety and sustained efficacy of VPRIV.
› Verified 5 days ago
Dr. Natalie W Philbrick, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3301 S Alameda St Ste 201, Corpus Christi, TX 78411 Phone: 361-857-2900 | |
Dr. Gregg Lee Silverman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 613 Elizabeth St, Suite 402, Corpus Christi, TX 78404 Phone: 361-887-2900 Fax: 361-887-0942 | |
Dr. Stanley Cal, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4918 Ayers St Ste 130, Corpus Christi, TX 78415 Phone: 361-400-4355 Fax: 888-815-1095 | |
James Michael Neff, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7121 S Padre Island Dr, Corpus Christi, TX 78412 Phone: 361-696-6200 Fax: 361-696-6054 | |
Dr. John Douglas Pappas, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1521 S Staples St Ste 700, Corpus Christi, TX 78404 Phone: 361-888-8271 Fax: 361-885-3699 | |
Thomas Alexander, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1202 3rd St, Corpus Christi, TX 78404 Phone: 361-883-3962 Fax: 361-883-5398 | |
Marie Charisse Impe, NP Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 5802 Saratoga Blvd Ste 200, Corpus Christi, TX 78414 Phone: 361-696-6200 |